Condition: AORTIC VALVE DISEASES · Bicuspid Aortic Valve (BAV) · Sponsor: Xijing Hospital
Safety, effectiveness and durability of Sapien 3 transcatheter aortic valve replacement in young aortic valve stenosis patients from China：A multi-center, retrospective and prospective, single arm, observational study
This description comes directly from the study's public registry record.
Jian Yang, MD, PhD · +8613892828016 · yangjian@fmmu.edu.cn
Meng en Zhai, PhD · +8617782801836 · zhaimengen@126.com
Always discuss trial participation with your own doctor first.
| Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University | Xi'an, Shaanxi, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, Sichuan, China | Not Yet Recruiting |
| Fuwai Hospital, Chinese Academy of Medical Sciences | Beijing, China | Not Yet Recruiting |
| Shanghai Zhongshan Hospital, Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06830499